The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer.
Cathrine Fonnesbech HjorthPer DamkierTore B StageSøren FeddersenStephen Hamilton-DutoitBent EjlertsenTimothy L LashHenrik BøggildHenrik T SørensenDeirdre Cronin-FentonPublished in: Cancer chemotherapy and pharmacology (2023)
Overall, the SNPs examined in the study did not influence return-to-work or stable labor market attachment after breast cancer in premenopausal women. Our findings did suggest that the outcomes were delayed in homozygote carriers of CYP3A5 rs776746, though the number of homozygotes was low.